TrialLeukemia2024

Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.

Nadine Abdallah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.